A double-blinded, randomized controlled trial: comparison of the effectiveness of two single-dose vaginal tablets, Sertaconazole vs Clotrimazole, for treating vaginal candidiasis
Phase 4
- Conditions
- -Vaginal candidiasis-Vaginal tablet-Sertaconazole-Clotrimazole
- Registration Number
- TCTR20190308004
- Lead Sponsor
- Pacific Healthcare (Thailand) Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending (Not yet recruiting)
- Sex
- Female
- Target Recruitment
- 100
Inclusion Criteria
Vaginal candidiasis
Exclusion Criteria
-Hypersensitivity to sertaconazole or clotrimazole
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Cure rate of vaginal candidiasis 2 weeks Wet preparation
- Secondary Outcome Measures
Name Time Method Side effect 2 weeks Questions